To amend the National Quantum Initiative Act to make certain additions relating to quantum modeling and simulation, and for other purposes.

HR7749, the "Quantum in Practice Act," amends the National Quantum Initiative Act by explicitly adding "modeling, simulation" to the definition of Quantum Information Science and including "quantum molecular modeling or simulation" in the Quantum Information Science Research Program. This is not a funding bill; it is a directive to focus existing and future federal quantum research efforts on practical applications in molecular modeling and simulation. This shift accelerates the development of quantum solutions for drug discovery, advanced materials, and energy storage, creating a clear demand signal for quantum computing capabilities. The money trail for this initiative will flow through existing federal research grants and contracts under the National Quantum Initiative. Agencies like the Department of Energy, National Science Foundation, and Department of Defense will prioritize proposals and projects that align with quantum molecular modeling and simulation. Companies with established quantum research divisions, such as IBM ($IBM), Google ($GOOGL) (via Alphabet), Microsoft ($MSFT), and Amazon ($AMZN) (via AWS), are positioned to secure these contracts and grants. Additionally, companies in materials science and pharmaceuticals that can leverage quantum simulation, like Honeywell ($HON) for advanced materials, DuPont ($DD), and Ecolab ($ECL) for chemical processes, will see accelerated R&D capabilities. Historically, federal directives in emerging technologies have driven significant market growth. For example, the National Nanotechnology Initiative, established in 2000, led to substantial increases in R&D spending and the creation of new industries. While direct stock price correlation is difficult for a definitional amendment, the increased focus on quantum applications will attract private investment. When the National Quantum Initiative Act was signed into law in December 2018, major tech companies with quantum aspirations, such as IBM ($IBM), saw increased investor interest, with its stock rising approximately 5% in the subsequent month as the market recognized the long-term potential of federal support for quantum technologies. This bill reinforces that commitment. Specific winners include IBM ($IBM) due to its Qiskit platform and extensive quantum hardware, Google ($GOOGL) with its quantum AI efforts, Microsoft ($MSFT) with Azure Quantum, and Amazon ($AMZN) through AWS Braket. These companies provide the foundational quantum computing infrastructure and services that will be essential for advanced modeling and simulation. Companies in sectors that will directly benefit from quantum simulation breakthroughs, such as pharmaceutical companies and advanced materials manufacturers, will also see long-term gains through accelerated innovation. Losers are not directly created by this bill, but companies that fail to invest in quantum capabilities will fall behind competitors who leverage these new tools. This bill has been referred to the House Committee on Science, Space, and Technology. Given the bipartisan sponsorship (12 cosponsors, including members from both parties) and the non-controversial nature of scientific advancement, it has a moderate to high chance of passing the House. If it passes the House, it will move to the Senate. The earliest this bill could become law is late 2026 or early 2027, but the signal to the market is immediate: quantum modeling and simulation are now a federal priority.